Dogrul, AhmetSeyrek, MelikYalcin, BulentUlugol, Ahmet2024-06-122024-06-1220120278-58461878-4216https://doi.org/10.1016/j.pnpbp.2012.01.007https://hdl.handle.net/20.500.14551/18405Cannabinoids produce antinociceptive and antihyperalgesic effects mainly through activation of the inhibitory CB1 receptors. The demonstration that antinociceptive effects of systemic cannabinoids are significantly diminished following surgical dorsolateral funiculus lesion provides evidence that supraspinal sites and descending pain modulatory pathways play crucial roles in systemic cannabinoid analgesia. In this review, we will firstly provide a background, brief overview of descending modulatory pathways followed by descending pathways implicated in cannabinoid analgesia. We will then describe the recent evidence of the involvement of descending serotonergic and noradrenergic pathways in CB1 receptor-mediated antinociception. This review will provide evidences that systemically administered cannabinoids reinforce the descending serotonergic and noradrenergic pathways to produce acute antinociceptive effects via spinal 5-HT7, 5-HT2A and alpha-2 adrenoceptors activation. (C) 2012 Elsevier Inc. All rights reserved.en10.1016/j.pnpbp.2012.01.007info:eu-repo/semantics/closedAccessAnalgesiaCannabinoidDescending PathwaysEndocannabinoidNoradrenalineSerotoninCannabinoid-Induced AntinociceptionNucleus Raphe MagnusVentromedial Medulla NeuronsPeriaqueductal GrayDorsal RapheLocus-CoeruleusSpinal 5-Ht7Endocannabinoid SystemPain ModulationTactile AllodyniaReview Article38197105Q1WOS:0003072582000122-s2.0-8486290334122300745Q1